IRIS
COLUCCI, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.400
AS - Asia 3.489
EU - Europa 3.386
SA - Sud America 847
AF - Africa 174
Continente sconosciuto - Info sul continente non disponibili 122
OC - Oceania 6
Totale 18.424
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.261
SG - Singapore 1.485
IT - Italia 975
CN - Cina 880
BR - Brasile 689
HK - Hong Kong 470
DE - Germania 466
SE - Svezia 454
RU - Federazione Russa 363
FR - Francia 274
UA - Ucraina 259
FI - Finlandia 230
VN - Vietnam 167
GB - Regno Unito 162
IN - India 113
BD - Bangladesh 77
CI - Costa d'Avorio 63
CA - Canada 58
AR - Argentina 56
IE - Irlanda 43
TR - Turchia 40
MX - Messico 38
ZA - Sudafrica 38
IQ - Iraq 34
EC - Ecuador 27
ID - Indonesia 27
NL - Olanda 27
PK - Pakistan 27
PL - Polonia 27
PH - Filippine 25
BE - Belgio 24
CO - Colombia 24
SA - Arabia Saudita 24
JP - Giappone 22
VE - Venezuela 20
MA - Marocco 17
MY - Malesia 14
ES - Italia 13
UZ - Uzbekistan 13
PY - Paraguay 12
AT - Austria 11
EG - Egitto 11
JO - Giordania 11
TN - Tunisia 11
LT - Lituania 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
DK - Danimarca 8
DO - Repubblica Dominicana 7
KR - Corea 7
CZ - Repubblica Ceca 6
ET - Etiopia 6
IL - Israele 6
JM - Giamaica 6
AU - Australia 5
GR - Grecia 5
HN - Honduras 5
KE - Kenya 5
SM - San Marino 5
SV - El Salvador 5
UY - Uruguay 5
AL - Albania 4
AO - Angola 4
CR - Costa Rica 4
IR - Iran 4
KZ - Kazakistan 4
NG - Nigeria 4
NP - Nepal 4
PA - Panama 4
AZ - Azerbaigian 3
EU - Europa 3
GT - Guatemala 3
KW - Kuwait 3
LB - Libano 3
NI - Nicaragua 3
PE - Perù 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CH - Svizzera 2
GD - Grenada 2
KG - Kirghizistan 2
MD - Moldavia 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
DJ - Gibuti 1
DM - Dominica 1
Totale 18.286
Salva come PNG Salva come JPEG
Città #
Fairfield 1.157
Woodbridge 1.028
Ashburn 898
Singapore 788
Houston 699
Chandler 666
Jacksonville 610
San Jose 529
Seattle 504
Hong Kong 466
Cambridge 412
Ann Arbor 397
Milan 389
Wilmington 388
Nyköping 380
Beijing 253
Council Bluffs 177
Roxbury 161
Lawrence 159
Nanjing 158
Lauterbourg 143
Rome 118
New York 112
Dallas 103
Bari 98
Des Moines 97
Boardman 93
Los Angeles 90
Helsinki 73
Santa Clara 67
São Paulo 64
Abidjan 63
Ho Chi Minh City 63
Princeton 62
San Diego 61
Brooklyn 57
Columbus 53
Inglewood 52
Strasbourg 48
Figino 45
Hebei 42
Nanchang 41
Shenyang 41
Dublin 39
Grafing 37
London 37
Buffalo 32
Chicago 31
Hanoi 30
Frankfurt am Main 27
Atlanta 26
Tianjin 25
Brussels 24
Orem 23
Turin 23
Jiaxing 21
Moscow 21
Belo Horizonte 20
Changsha 20
Dearborn 20
Johannesburg 20
Phoenix 20
Warsaw 20
Boston 19
Naples 19
Pune 19
Paris 18
Tokyo 18
Mexico City 17
Rio de Janeiro 17
Falkenstein 16
Munich 16
Baghdad 15
Dhaka 13
Guangzhou 13
Montreal 13
Poplar 13
Quito 12
Toronto 12
Denver 11
Jakarta 11
Manchester 11
Mumbai 11
San Francisco 11
Tashkent 11
Amsterdam 10
Auburn Hills 10
Bologna 10
Brasília 10
Campinas 10
Curitiba 10
Florence 10
Genoa 10
Redwood City 10
Amman 9
Charlotte 9
Kunming 9
Medellín 9
Nuremberg 9
San Mateo 9
Totale 12.881
Salva come PNG Salva come JPEG
Nome #
Coagulopathy of Acute Sepsis 226
Platelet drop and fibrinolytic shutdown in patients with sepsis 218
Fisiologia dell'Emostasi 206
Histones differentially modulate the anticoagulant and profibrinolytic activities of heparin, heparin derivatives and dabigatran. 199
Factor IX-Padua enhances the fibrinolytic resistance of plasma clots 192
FVIII/VWF complex displays a greater pro-hemostatic activity than FVIII preparations devoid of VWF. Study in plasma and cell-based models 185
Coagulation activation is associated with nicotinamide adenine dinucleotide phosphate oxidase-dependent reactive oxygen species generation in hemodialysis patients. 180
Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation 179
Grape intake reduces thrombin generation and enhances plasma fibrinolysis. Potential role of circulating procoagulant microparticles 179
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression 176
A modified prothrombin time to measure the anticoagulant activity of dabigatran 168
Antithrombotic activity of 12 table grape varieties. Relationship with polyphenolic profile 166
Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection 163
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein C reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation 160
D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis 159
Influence of cell-associated tissue factor concentration on the anticoagulant activity of dabigatran. A possible explanation for the reduced incidence of intracranial bleeding 158
Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors 154
Effect of ochratoxin A on prothrombotic and proinflammatory activities of stimulated blood mononuclear cells 151
Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism 151
Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor 151
Cultured human endothelial cells generate tissue factor in response to endotoxin 148
Blood and tissue fibrinolytic profile in patients with colorectal cancer 148
Platelets and fibrinolysis 148
Gene expression signature induced by grape intake in healthy subjects reveals wide-spread beneficial effects on peripheral blood mononuclear cells 148
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 147
Tissue factor in health and disease 146
CHANGES IN THE COAGULATION-FIBRINOLYSIS BALANCE OF ENDOTHELIAL-CELLS AND MONONUCLEAR PHAGOCYTES - ROLE IN DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH INFECTIOUS-DISEASES 143
Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway 142
Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein. 141
Co-administration of low molecular weight heparin enhances the profibrinolytic effect of warfarin through different mechanisms. 139
Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells 139
A hitherto undescribed defect of platelet coagulant activity in polycythaemia vera and essential thrombocythaemia. 139
Reduced generation of procoagulant activity by endotoxin-stimulated mononuclear cells from patients with chronic myeloid leukaemia. 137
Hyperprothrombinemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis 137
In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis. Study in healthy subjects and correlation with blood fibrinolytic parameters 136
Sepsis, thrombosis and organ dysfunction 136
Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis 135
A ROLE FOR PLATELETS AND THROMBIN IN THE JUVENILE STROKE OF 2 SIBLINGS WITH DEFECTIVE THROMBIN-ADSORBING CAPACITY OF FIBRIN(OGEN) 134
Role of leucocyte procoagulant activity in endotoxin-induced DIC: evidence from comparative studies in rats and rabbits. 133
Anomalie cellulari e plasmatiche della coagulazione e della fibrinolisi dei linfomi ed effetto della terapia 133
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors 133
Low D-dimer levels in sepsis: Good or bad? 132
Cellular coagulation-fibrinolysis balance and atherosclerosis 131
Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots 131
Cancer cell procoagulant activity: evaluation by an amidolytic assay. 131
Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation 129
Cellular and plasmatic anomalies of the coagulation system and fibrinolysis in children with lymphomas and influence of cytostatic treatment 127
ENHANCED ENDOTHELIAL TISSUE FACTOR BUT NORMAL THROMBOMODULIN IN ENDOTOXIN-TREATED RABBITS. 127
Extracellular histones promote fibrinolysis by single-chain urokinase-type plasminogen activator in a factor seven activating protease-dependent way 127
NOVEL GLUCOSE-CONJUGATED HIGHLY POTENT DUAL THROMBIN AND FACTOR Xa INHIBITORS AS POTENTIAL ANTITHROMBOTICS 126
Alterazioni dell'equilibrio coagulativo-fibrinolitico dei monociti e della capacità fibrinolitica plasmatica dei linfomi 125
Cancer cell procoagulant: a novel vitamin K-dependent activity. 125
TAFI deficiency in liver cirrhosis: relation with plasma fibrinolysis and survival 124
In vitro inhibition of monocyte tissue factor and PAI-2 production by Ochratoxin A 124
Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential 123
Effect of Ochratoxin A on prothrombotic and proinflammatory activities of stimulated blood mononuclear cells 123
Does inhibiting Sur1 complement rtPA in cerebral ischemia? 122
Diversi fattori contribuiscono alla ipofibrinolisi nei bambini obesi 122
Thrombolysis enhancing activity of a low molecular weight dermatan sulfate (Desmin 370) in experimental pulmonary embolism in rats. 121
Stroke in two young siblings with congenital dysfibrinogenemia. 121
Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. 121
Fibrin down-regulates LPS- and PMA- induced tissue factor expression by blood mononuclear cells 120
Monocytes, but not endothelial cells, downregulate the anticoagulant activity of activated protein C 119
Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice 119
Ochratoxin A inhibits the production of tissue factor and plasminogen activator inhibitor-2 by human blood mononuclear cells: Another potential mechanism of immune-suppression 119
Evidence that fibrynolitic changes in paediatric obesity translate in a hypofibrinolytic state. Relative contribution of TAFI and PAI-1 118
Estressione del tisuue factor e del vasular endothelial growth factor nel carcinoma del colon retto 118
FAILURE OF WARFARIN TO AFFECT THE TISSUE FACTOR ACTIVITY AND THE METASTATIC POTENTIAL OF MURINE FIBRO-SARCOMA CELLS. 117
Procoagulant activity of sarcoma sublines with different metastatic potential 116
Unbalanced coagulation-fibrinolysis potential during L-Asparaginase therapy in children with acute lymphoblastic leukaemia 116
URINARY PROCOAGULANT AND FIBRINOLYTIC-ACTIVITY IN HUMAN GLOMERULONEPHRITIS - RELATIONSHIP WITH RENAL-FUNCTION 115
Increased mononuclear cell tissue factor and type-2 plasminogen activator inhibitor and reduced plasma fibrinolytic capacity in children with lymphoma 115
Helicobacter pylori neutrophil activating protein stimulates tissue factor and plasminogen inhibitor-2 production by human blood mononuclear cells 115
Alterazioni dell'equilibrio coagulativo-fibrinolitico dei monociti e della capacità fibrinolitica plasmatica nei linfomi 115
The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood 115
Complement-dependent and complement-independent interactions of bacterial lipopolysaccharides and mucopeptides with rabbit and human platelets. 114
Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency. 114
REDUCED FIBRINOLYTIC-ACTIVITY IN GLOMERULI ISOLATED FROM RABBITS INFUSED WITH TUMOR-NECROSIS-FACTOR. 114
Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies 110
The paradoxical antifibrinolytic effect of dabigatran and argatroban in the presence of soluble thrombomodulin is unrelated to protein C-dependent increase of thrombin generation. 110
Reduction of the plasma levels of tissue plasminogen activator after infusion of a lipid emulsion in humans 109
Expression of tissue factor and vascular endothelial growth factor in colorectal carcinoma 109
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. 108
Increased macrophage procoagulant activity but normal endothelial thrombomodulin in rabbits fed an atherogenic diet 107
Prevention and therapy of experimental venous thrombosis in rabbits by desmin 370 107
NOVEL GLUCOSE-CONJUGATED HIGHLY POTENT DUAL THROMBIN AND FACTOR Xa INHIBITORS AS POTENTIAL ANTITHROMBOTICS 107
Early increase of a new platelet coagulant activity in rats fed a thrombogenic diet. 107
Evidence that cells from experimental tumours can activate coagulation factor X. British journal of cancer. 106
An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia 106
Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis 105
Procoagulant properties of bare and highly-PEGylated vinyl-modified silica nanoparticles 105
Skin extracts from 2 italian table grapes (italia and palieri) inhibit tissue factor expression by human blood mononuclear cells 104
EXPERIMENTAL ENDOTOXEMIA AS A MODEL OF IMPAIRED FIBRINOLYSIS 103
Evidence suggesting that a thrombin-dependent serum factor enhances fibrinolysis 102
Rebuttal to: Effect of heparin on TAFI-dependent inhibition of fibrinolysis 102
Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis 101
HEMOSTATIC VARIABLES IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - EFFECT OF REGULAR PLASMA-CHOLESTEROL REMOVAL BY LOW-DENSITY-LIPOPROTEIN APHERESIS 101
Effect of Helicobacter pylori lipopolysaccaride and LPS derivates on the production of tissue factor and plasminogen activator inhibitor type 2 by human blood mononuclear cells 101
Coagulation-fibrinolysis changes during off-pump bypass: effect of two heparin doses 101
PLASMINOGEN ACTIVATOR INHIBITOR IN THE BLOOD OF PATIENTS WITH CORONARY-ARTERY DISEASE. 100
Totale 13.265
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.688
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.688
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022911 0 0 11 40 60 50 63 53 80 62 199 293
2022/20231.795 263 191 134 163 211 233 23 169 326 13 35 34
2023/2024463 59 102 15 35 29 102 15 21 5 10 18 52
2024/20252.482 78 32 213 100 46 181 162 244 93 103 369 861
2025/20264.906 701 221 300 586 554 209 555 133 376 441 130 700
2026/2027596 151 232 213 0 0 0 0 0 0 0 0 0
Totale 18.424